Jazz Pharmaceuticals
JAZZ
#2291
Rank
HK$48.71 B
Marketcap
HK$802.08
Share price
3.03%
Change (1 day)
-5.94%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): HK$3.65 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are HK$4.06 Billion. , an increase over its 2023 earnings that were of HK$2.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 HK$3.64 B57.87%
2023 HK$2.31 B-179.92%
2022 -HK$2.9 Billion230.37%
2021 -HK$0.88 Billion-141.02%
2020 HK$2.13 B-39.45%
2019 HK$3.52 B-14.2%
2018 HK$4.10 B20.03%
2017 HK$3.42 B-17.15%
2016 HK$4.13 B22.14%
2015 HK$3.38 B187.64%
2014 HK$1.17 B-50.79%
2013 HK$2.38 B73.63%
2012 HK$1.37 B41.69%
2011 HK$0.97 B116.61%
2010 HK$0.44 B262.77%
2009 HK$0.12 B-111.33%
2008 -HK$1.1 Billion1.31%
2007 -HK$1.08 Billion77.8%
2006 -HK$0.61 Billion36.59%
2005 -HK$0.45 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$18.56 Billion-608.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$16.26 B 345.78%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$105.82 B 2,799.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$2.19 Billion-159.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel